Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Echinaforce Junior vs Vitamin C for Prevention of Viral Respiratory Tract Infections in Children
NCT02971384Phase 3Completed
- Sponsor
- A.Vogel
- Start
- Nov 2016
- Primary completion
- Aug 2017
- Modality
- Botanical Extract
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of echinacea purpurea extract in viral respiratory tract infection (2 arms), sponsored by A.Vogel. Primary endpoint: cumulative number of cold days at 4 months. Started Nov 2016; status: completed.
02
Drugs
echinacea purpurea extract
03
Conditions
viral respiratory tract infection
Beyond the preview
Go deeper on NCT02971384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02971384.